MYO Myomo, Inc.
AMEXHealthcareAs of 2026-07-10 16:00
Why MYO matters now
Myomo, Inc. (MYO) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.10 with -4.76% on the session and $42.5M in market capitalization.
The latest indexable market news headline is "Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript" from Seeking Alpha.
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
AMEX
Beta
1.46
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.